
Patenting Privation (Part III): Empowering Revenge
Much like America's waistline, a dispute between Eli Lilly and a large compounder called Empower Pharmacy is expanding.
Much like America's waistline, a dispute between Eli Lilly and a large compounder called Empower Pharmacy is expanding.
An interesting scenario where the limited lifespan of a patent renders it less effective as a means of keeping out a competitive product from the market.
Outdated billing is costing law firms money. Discover how clear, modern billing practices boost profits, trust, and cash flow in 2025.
Matthew Allan Newman shares his experiences navigating the Chinese IP landscape.
A mass exodus is predicted if this happens.
AI is the next big thing, and most developers want to protect those programs and systems. The answer is intellectual property protection and specifically patent protection.
2025 is off to a rip-roaring start in the world of patent law!
Share your insights in this brief survey.
These big bonuses keep attracting top talent.
Patent litigation promises to never be a boring enterprise, at least in terms of subject matter.
Pretty big praise.
Eli Mazour’s expansion of the Clause 8 podcast experience into the Voice of IP newsletter is a welcome one.
Discover how to gain more control over your firm’s finances and unlock smarter growth strategies—take a quick financial visibility quiz designed for law firms.
It is likely heartening to Sonos to see the handling of a patent case get overturned by the CAFC in the same week that Sonos lodged its own criticisms of the same judge to the same appellate court.
This year's report highlights how well modern patent litigation has rebounded from the pandemic.
Come on, Roberts!
A look at the potential consequences of the Federal Circuit’s reversal of VLSI’s $2 billion March 2021 WDTX verdict against Intel.
Let's revisit some of the conditions that led to the viability of IP Edge’s volume-based nuisance settlement approach to patent litigation.